Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

S. K. Sarin, M. Kumar, G. K. Lau, Z. Abbas, H. L.Y. Chan, C. J. Chen, D. S. Chen, H. L. Chen, P. J. Chen, R. N. Chien, A. K. Dokmeci, Ed Gane, J. L. Hou, W. Jafri, J. Jia, J. H. Kim, C. L. Lai, H. C. Lee, S. G. Lim, C. J. LiuS. Locarnini, M. Al Mahtab, R. Mohamed, M. Omata, J. Park, T. Piratvisuth, B. C. Sharma, J. Sollano, F. S. Wang, L. Wei, M. F. Yuen, S. S. Zheng, J. H. Kao

Research output: Contribution to journalEditorial

654 Citations (Scopus)

Abstract

Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection and the potential for therapy of the resultant disease is continuously improving. New data have become available since the previous APASL guidelines for management of HBV infection were published in 2012. The objective of this manuscript is to update the recommendations for the optimal management of chronic HBV infection. The 2015 guidelines were developed by a panel of Asian experts chosen by the APASL. The clinical practice guidelines are based on evidence from existing publications or, if evidence was unavailable, on the experts’ personal experience and opinion after deliberations. Manuscripts and abstracts of important meetings published through January 2015 have been evaluated. This guideline covers the full spectrum of care of patients infected with hepatitis B, including new terminology, natural history, screening, vaccination, counseling, diagnosis, assessment of the stage of liver disease, the indications, timing, choice and duration of single or combination of antiviral drugs, screening for HCC, management in special situations like childhood, pregnancy, coinfections, renal impairment and pre- and post-liver transplant, and policy guidelines. However, areas of uncertainty still exist, and clinicians, patients, and public health authorities must therefore continue to make choices on the basis of the evolving evidence. The final clinical practice guidelines and recommendations are presented here, along with the relevant background information.

Original languageEnglish
Pages (from-to)1-98
Number of pages98
JournalHepatology International
Volume10
Issue number1
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Hepatitis B
Practice Guidelines
Hepatitis B virus
Virus Diseases
Guidelines
Chronic Hepatitis B
Natural History
Preclinical Drug Evaluations
Manuscripts
Liver
Coinfection
Terminology
Uncertainty
Antiviral Agents
Publications
Liver Diseases
Counseling
Patient Care
Vaccination
Public Health

All Science Journal Classification (ASJC) codes

  • Hepatology

Cite this

Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., ... Kao, J. H. (2016). Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatology International, 10(1), 1-98. https://doi.org/10.1007/s12072-015-9675-4
Sarin, S. K. ; Kumar, M. ; Lau, G. K. ; Abbas, Z. ; Chan, H. L.Y. ; Chen, C. J. ; Chen, D. S. ; Chen, H. L. ; Chen, P. J. ; Chien, R. N. ; Dokmeci, A. K. ; Gane, Ed ; Hou, J. L. ; Jafri, W. ; Jia, J. ; Kim, J. H. ; Lai, C. L. ; Lee, H. C. ; Lim, S. G. ; Liu, C. J. ; Locarnini, S. ; Al Mahtab, M. ; Mohamed, R. ; Omata, M. ; Park, J. ; Piratvisuth, T. ; Sharma, B. C. ; Sollano, J. ; Wang, F. S. ; Wei, L. ; Yuen, M. F. ; Zheng, S. S. ; Kao, J. H. / Asian-Pacific clinical practice guidelines on the management of hepatitis B : a 2015 update. In: Hepatology International. 2016 ; Vol. 10, No. 1. pp. 1-98.
@article{4ca8a9d28b6b44c6b9eec2753b54558e,
title = "Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update",
abstract = "Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection and the potential for therapy of the resultant disease is continuously improving. New data have become available since the previous APASL guidelines for management of HBV infection were published in 2012. The objective of this manuscript is to update the recommendations for the optimal management of chronic HBV infection. The 2015 guidelines were developed by a panel of Asian experts chosen by the APASL. The clinical practice guidelines are based on evidence from existing publications or, if evidence was unavailable, on the experts’ personal experience and opinion after deliberations. Manuscripts and abstracts of important meetings published through January 2015 have been evaluated. This guideline covers the full spectrum of care of patients infected with hepatitis B, including new terminology, natural history, screening, vaccination, counseling, diagnosis, assessment of the stage of liver disease, the indications, timing, choice and duration of single or combination of antiviral drugs, screening for HCC, management in special situations like childhood, pregnancy, coinfections, renal impairment and pre- and post-liver transplant, and policy guidelines. However, areas of uncertainty still exist, and clinicians, patients, and public health authorities must therefore continue to make choices on the basis of the evolving evidence. The final clinical practice guidelines and recommendations are presented here, along with the relevant background information.",
author = "Sarin, {S. K.} and M. Kumar and Lau, {G. K.} and Z. Abbas and Chan, {H. L.Y.} and Chen, {C. J.} and Chen, {D. S.} and Chen, {H. L.} and Chen, {P. J.} and Chien, {R. N.} and Dokmeci, {A. K.} and Ed Gane and Hou, {J. L.} and W. Jafri and J. Jia and Kim, {J. H.} and Lai, {C. L.} and Lee, {H. C.} and Lim, {S. G.} and Liu, {C. J.} and S. Locarnini and {Al Mahtab}, M. and R. Mohamed and M. Omata and J. Park and T. Piratvisuth and Sharma, {B. C.} and J. Sollano and Wang, {F. S.} and L. Wei and Yuen, {M. F.} and Zheng, {S. S.} and Kao, {J. H.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/s12072-015-9675-4",
language = "English",
volume = "10",
pages = "1--98",
journal = "Hepatology International",
issn = "1936-0533",
publisher = "Springer New York",
number = "1",

}

Sarin, SK, Kumar, M, Lau, GK, Abbas, Z, Chan, HLY, Chen, CJ, Chen, DS, Chen, HL, Chen, PJ, Chien, RN, Dokmeci, AK, Gane, E, Hou, JL, Jafri, W, Jia, J, Kim, JH, Lai, CL, Lee, HC, Lim, SG, Liu, CJ, Locarnini, S, Al Mahtab, M, Mohamed, R, Omata, M, Park, J, Piratvisuth, T, Sharma, BC, Sollano, J, Wang, FS, Wei, L, Yuen, MF, Zheng, SS & Kao, JH 2016, 'Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update', Hepatology International, vol. 10, no. 1, pp. 1-98. https://doi.org/10.1007/s12072-015-9675-4

Asian-Pacific clinical practice guidelines on the management of hepatitis B : a 2015 update. / Sarin, S. K.; Kumar, M.; Lau, G. K.; Abbas, Z.; Chan, H. L.Y.; Chen, C. J.; Chen, D. S.; Chen, H. L.; Chen, P. J.; Chien, R. N.; Dokmeci, A. K.; Gane, Ed; Hou, J. L.; Jafri, W.; Jia, J.; Kim, J. H.; Lai, C. L.; Lee, H. C.; Lim, S. G.; Liu, C. J.; Locarnini, S.; Al Mahtab, M.; Mohamed, R.; Omata, M.; Park, J.; Piratvisuth, T.; Sharma, B. C.; Sollano, J.; Wang, F. S.; Wei, L.; Yuen, M. F.; Zheng, S. S.; Kao, J. H.

In: Hepatology International, Vol. 10, No. 1, 01.01.2016, p. 1-98.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Asian-Pacific clinical practice guidelines on the management of hepatitis B

T2 - a 2015 update

AU - Sarin, S. K.

AU - Kumar, M.

AU - Lau, G. K.

AU - Abbas, Z.

AU - Chan, H. L.Y.

AU - Chen, C. J.

AU - Chen, D. S.

AU - Chen, H. L.

AU - Chen, P. J.

AU - Chien, R. N.

AU - Dokmeci, A. K.

AU - Gane, Ed

AU - Hou, J. L.

AU - Jafri, W.

AU - Jia, J.

AU - Kim, J. H.

AU - Lai, C. L.

AU - Lee, H. C.

AU - Lim, S. G.

AU - Liu, C. J.

AU - Locarnini, S.

AU - Al Mahtab, M.

AU - Mohamed, R.

AU - Omata, M.

AU - Park, J.

AU - Piratvisuth, T.

AU - Sharma, B. C.

AU - Sollano, J.

AU - Wang, F. S.

AU - Wei, L.

AU - Yuen, M. F.

AU - Zheng, S. S.

AU - Kao, J. H.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection and the potential for therapy of the resultant disease is continuously improving. New data have become available since the previous APASL guidelines for management of HBV infection were published in 2012. The objective of this manuscript is to update the recommendations for the optimal management of chronic HBV infection. The 2015 guidelines were developed by a panel of Asian experts chosen by the APASL. The clinical practice guidelines are based on evidence from existing publications or, if evidence was unavailable, on the experts’ personal experience and opinion after deliberations. Manuscripts and abstracts of important meetings published through January 2015 have been evaluated. This guideline covers the full spectrum of care of patients infected with hepatitis B, including new terminology, natural history, screening, vaccination, counseling, diagnosis, assessment of the stage of liver disease, the indications, timing, choice and duration of single or combination of antiviral drugs, screening for HCC, management in special situations like childhood, pregnancy, coinfections, renal impairment and pre- and post-liver transplant, and policy guidelines. However, areas of uncertainty still exist, and clinicians, patients, and public health authorities must therefore continue to make choices on the basis of the evolving evidence. The final clinical practice guidelines and recommendations are presented here, along with the relevant background information.

AB - Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection and the potential for therapy of the resultant disease is continuously improving. New data have become available since the previous APASL guidelines for management of HBV infection were published in 2012. The objective of this manuscript is to update the recommendations for the optimal management of chronic HBV infection. The 2015 guidelines were developed by a panel of Asian experts chosen by the APASL. The clinical practice guidelines are based on evidence from existing publications or, if evidence was unavailable, on the experts’ personal experience and opinion after deliberations. Manuscripts and abstracts of important meetings published through January 2015 have been evaluated. This guideline covers the full spectrum of care of patients infected with hepatitis B, including new terminology, natural history, screening, vaccination, counseling, diagnosis, assessment of the stage of liver disease, the indications, timing, choice and duration of single or combination of antiviral drugs, screening for HCC, management in special situations like childhood, pregnancy, coinfections, renal impairment and pre- and post-liver transplant, and policy guidelines. However, areas of uncertainty still exist, and clinicians, patients, and public health authorities must therefore continue to make choices on the basis of the evolving evidence. The final clinical practice guidelines and recommendations are presented here, along with the relevant background information.

UR - http://www.scopus.com/inward/record.url?scp=84984562922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984562922&partnerID=8YFLogxK

U2 - 10.1007/s12072-015-9675-4

DO - 10.1007/s12072-015-9675-4

M3 - Editorial

C2 - 26563120

AN - SCOPUS:84984562922

VL - 10

SP - 1

EP - 98

JO - Hepatology International

JF - Hepatology International

SN - 1936-0533

IS - 1

ER -